Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.

Suppr

超能文献

作者信息

Semon J H, Grindey G B

出版信息

Cancer Res. 1978 Sep;38(9):2905-11.

PMID:679199

Abstract

摘要

相似文献

Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.

Cancer Res. 1978 Sep;38(9):2905-11.

Influence of concomitant infusion of thymidine and inosine on methotrexate activity in normal and P388-bearing mice.

Eur J Cancer Clin Oncol. 1984 Dec;20(12):1527-32. doi: 10.1016/0277-5379(84)90146-9.

Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusion.

Antibiot Chemother (1971). 1978;23:295-304. doi: 10.1159/000401492.

Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.

Cancer Treat Rep. 1985 Jul-Aug;69(7-8):867-74.

Synergism between purines and thymidine (TDR) in reversal of methotrexate (MTX) toxicity in mice using continuous infusions.使用连续输注法研究嘌呤与胸腺嘧啶核苷（TDR）在逆转小鼠甲氨蝶呤（MTX）毒性中的协同作用。

Adv Exp Med Biol. 1984;165 Pt B:401-5. doi: 10.1007/978-1-4757-0390-0_76.

Effects of allopurinol on the therapeutic efficacy of methotrexate.别嘌醇对甲氨蝶呤治疗效果的影响。

Cancer Res. 1975 Jul;35(7):1702-5.

Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.

Cancer Treat Rep. 1977 May-Jun;61(3):445-50.

Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidines.嘌呤和嘧啶增强甲氨蝶呤的治疗效果并保护正常增殖组织。

Chem Biol Interact. 1977 Jul;18(1):119-28. doi: 10.1016/0009-2797(77)90147-8.

Combination chemotherapy in sequence for the treatment of L1210 leukemia.序贯联合化疗治疗L1210白血病

Cancer Res. 1978 Aug;38(8):2317-20.

New approaches to cancer chemotherapy with methotrexate.甲氨蝶呤用于癌症化疗的新方法。

N Engl J Med. 1975 Apr 17;292(16):846-51. doi: 10.1056/NEJM197504172921607.

引用本文的文献

Selective killing of preneoplastic and neoplastic cells by methotrexate with leucovorin.甲氨蝶呤联合亚叶酸钙对癌前细胞和肿瘤细胞的选择性杀伤作用

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4550-5. doi: 10.1073/pnas.95.8.4550.

Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate.血清胸苷浓度变化对甲氨蝶呤骨髓毒性的意义。

Cancer Chemother Pharmacol. 1981;5(4):221-6. doi: 10.1007/BF00434388.

Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).

Cancer Chemother Pharmacol. 1984;13(1):27-30. doi: 10.1007/BF00401442.

Studies on the designing of chemotherapy for gastric cancer in man, based on the tumor tissue concentration of anticancer agents.

Gastroenterol Jpn. 1982;17(4):295-300. doi: 10.1007/BF02774574.

Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.胸苷增强甲氨蝶呤和5-氟尿嘧啶对培养的人结肠癌的毒性作用。

Cancer Chemother Pharmacol. 1984;12(2):104-10. doi: 10.1007/BF00254600.

Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.结肠异种移植中的生化机制：胸苷酸合成酶作为治疗靶点

Invest New Drugs. 1989 Apr;7(1):59-69. doi: 10.1007/BF00178192.

Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.因胸苷酸合成酶缺乏而筛选出的人结肠腺癌突变体。

Proc Natl Acad Sci U S A. 1989 Feb;86(4):1377-81. doi: 10.1073/pnas.86.4.1377.

Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.影响5-氟尿嘧啶[6RS]亚叶酸联合用药对结肠腺癌异种移植瘤治疗活性的因素。

Cancer Chemother Pharmacol. 1992;30(6):423-32. doi: 10.1007/BF00685592.

Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.胸苷酸合成酶活性在甲氨蝶呤细胞毒性产生中的作用。

Proc Natl Acad Sci U S A. 1979 Nov;76(11):5924-8. doi: 10.1073/pnas.76.11.5924.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验